Financial Post
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences: Jefferies London Healthcare Conference Format: 1×1 Meetings Dates: November 20-21…
Read More
MindMed to Participate in Upcoming Investor Conferences
Business Wire
20:23
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences: Jefferies London Healthcare Conference Format: 1×1 Meetings Dates: November 20-21…
